Navigation Links
New Anti-HIV Weapons Found in Immune System
Date:7/8/2010

By Randy Dotinga
HealthDay Reporter

THURSDAY, July 8 (HealthDay News) -- Scientists report they've discovered possible new weapons in the war against HIV: antibody "soldiers" in the immune system that might prevent the AIDS virus from invading human cells.

According to the researchers, these newly found antibodies connect with and neutralize more than 90 percent of a group of HIV-1 strains, involving all major genetic subtypes of the virus.

That breadth of activity could potentially move research closer toward development of an HIV vaccine, although that goal still remains years away, at best, experts say.

The findings "show that the immune system can make very potent antibodies against HIV," said Dr. John Mascola, a vaccine researcher and co-author of two new studies published online July 8 in the journal Science.

"We are trying to understand why they exist in some patients and not others. That will help us in the vaccine design process," said Mascola.

Antibodies are warriors in the body's immune system that work to prevent infection. "Neutralizing" antibodies bind to germs and try to disable them, explained Ralph Pantophlet, an immunologist and assistant professor at Simon Fraser University in Burnaby, British Columbia, Canada.

With HIV, the antibodies are in a continual race to adjust to the virus, which evolves to escape detection. "The reason the antibodies generally do not work so well is because they're always playing catch up," said Pantophlet, who is familiar with the findings of the new studies.

However, some people's antibodies are known to cope especially well with HIV, although even these rare patients can't get rid of the virus entirely, Pantophlet said.

In the new studies, researchers report on three antibodies that appear to have major powers to fight off HIV. In a sense, the antibodies gum up a lock that the virus tries to pick to get into healthy cells, said Mascola, deputy director of the Vaccine Research Center at the U.S. National Institutes of Allergy and Infectious Diseases.

However, making antibodies in large enough quantities to boost the immune system remains a challenge, said Pantophlet.

While researchers haven't given up on that prospect, some think it's more feasible to use the new findings as another avenue to an AIDS vaccine. The idea would be to teach the body to produce the antibodies so the person is protected when exposed to the virus, Mascola said.

But that won't happen for some time, if at all. "Developing a vaccine always takes a fairly long period of research with some trial and error," Mascola said.

"The goal is to vaccinate individuals and have their own immune systems make an antibody like this," he said. "To do that, we have to design a new vaccine, study it first in animal models, and then try it in small scale human studies, and see if it does what we expect it to do. That takes a quite a bit of time and effort."

More information

To learn more about the immune system, see the U.S. National Library of Medicine.

SOURCES: John R. Mascola, M.D., Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.; Ralph Pantophlet, assistant professor, Faculty of Health Sciences, Simon Fraser University, Burnaby, B.C., Canada; July 9, 2010, Science


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Anti-HIV Drugs May Help Prevent Spread of Virus
2. One-third of antimalarial medicines sampled in 3 African nations found to be substandard
3. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. Stuttering Foundation Hails New Research
6. Autism Science Foundation Offers IMFAR Grants to Autism Stakeholders
7. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
8. Corbett Accel Healthcare Group Mourns Passing of Founder Frank J. Corbett
9. Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts
10. Kaiser Foundation Health Plan and Hospitals Report Fourth Quarter and Fiscal Year 2009 Financial Results
11. Instaflex Announces Proceeds Agreement with Arthritis Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Anti-HIV Weapons Found in Immune System
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to ... convenient service for Texas, they are expanding their presence in Dallas. One of the ... that will bring new jobs to the Dallas and Forth Worth market. STAT takes ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital health ... led by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and ... to serve more consumers who are managing chronic conditions or simply want ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/8/2016)... ... 2016 , ... Bill Mull Agencies, a Wichita-based firm offering ... central Kansas, is joining the Youth Horizons organization for a charity event that ... Wichita, Youth Horizons works to empower area children from unstable, troubled, or single-parent ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  Haemonetics Corporation (NYSE: HAE ) has ... an innovative software suite designed to help customers drive efficiency ... of NextGen DMS 4 improves core features and introduces innovations ... liter of plasma collected, enhancing quality and regulatory compliance and ... ...
(Date:12/8/2016)... SINGAPORE , BEIJING , and ... a leading commercial provider of genomic services and solutions with ... a Singapore biotechnology company; and the ... today that NovogeneAIT Genomics Singapore (NovogeneAIT) – a new joint ... whole genome sequencing (WGS) centre at Biopolis, Singapore ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: